Antithrombin III Progressive Function: A Biochemical Analysis

E. Gomperts,P. Izadi

DOI: https://doi.org/10.1055/s-0038-1652068

1983-07-01

Thrombosis and Haemostasis

Abstract:Antithrombin III (AT III) was measured in the various fractions obtained during the partial purification of AT III-Heparin Cofactor (AT III-HCF) via a heparin-bound affinity chromatography system. AT III antigen and HCF activity was present to some extent in all fractions, but significant progressive function was observed only in that obtained via PEG-4000 precipitation. This precipitate was applied to a Sephacryl-200 column. Fractions were collected and those demonstrating maximum AT III antigen and progressive thrombin inhibition were pooled and reapplied to the washed Sephacryl S-200 column. Fractions were collected and assayed via specific antisera for AT III, α1AT, α2M and α1 acid glycoprotein (α1AG) . AT III antigen and progressive function were confined primarily to one peak containing virtually no α2M, a low level of α1AT, and moderate quantities of α1AG. PAGE of the component showed AT III antigen separating into two bands. Assessment of the two other prominent bands showed no reactivity with antisera to α2M, α1AT or α1AG. PAGE-SDS showed a different pattern with the AT III doublet moving as a single band. These electrophoretic patterns were identical with that of the AT III-HCF purified by the heparin-affinity system. AT III antigen-two dimensional immunoelectrophoresis in the presence of heparin of both the Sephacryl and heparin- affinity purified components was very different with the Sephacryl purified AT III protein showing both a fast peak and a very prominent slow moving hump. The AT III heparin purified component showed primarily a fast component. These two fractions differed in one other respect in that AT III inhibition of thrombin was activated, heparin-like, by EDTA. This effect was totally absent in the heparin affinity purified AT III-HCF. On the basis of these observations it is postulated that AT III purified by the affinity system is biochemically altered resulting in an inability to respond functionally to non-heparin activating stimuli.